Bo King
Activist · DISC type CdBo King is an Associate Director in Clinical Development at Deciphera Pharmaceuticals, specializing in Phase I-II oncology trials. With over 15 years of experience in translational oncology, they leverage preclinical insights to advance novel therapeutics. Bo earned a PhD from Shinshu University in Japan.
Outside of their primary role, Bo is the founder of a health sciences company and works as a nutraceutical consultant. They are trilingual and have expressed a strong interest in the power of mindset, believing that how one reacts to lifes events is critically important for health and performance.
Unique fact: Bo won an inspiration award for successfully creating the very first in-vivo model for the rare disease AL Amyloidosis while at Janssen.
Read the full overview →How Bo shows up
They don’t always try to control the conversation but neither do they like yielding it fully. They focus on objectivity in a pitch and pay little attention to bells and whistles. They care equally about the product and its potential impact.
Topics Bo cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other Deciphera Pharmaceuticals Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.